TU
RDY icon

TDAM USA’s Dr. Reddy's Laboratories RDY Stock Holding History

TDAM USA’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,355
Closed -$467K – 385
2016
Q3 		$467K Sell
50,355
-500
-1% -$4.77K 0.02% 297
2016
Q2 		$521K Sell
50,855
-7,645
-13% -$70.1K 0.03% 281
2016
Q1 		$529K Sell
58,500
-2,820
-5% -$25.2K 0.03% 282
2015
Q4 		$568K Sell
61,320
-33,900
-36% -$371K 0.03% 280
2015
Q3 		$1.22M Sell
95,220
-21,545
-18% -$268K 0.06% 194
2015
Q2 		$1.29M Buy
116,765
+2,770
+2% +$30.6K 0.06% 202
2015
Q1 		$1.3M Buy
113,995
+74,915
+192% +$795K 0.05% 216
2014
Q4 		$394K Buy
39,080
+16,870
+76% +$178K 0.02% 260
2014
Q3 		$233K Buy
+22,210
New +$209K 0.01% 288

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

TDAM USA's RDY Position: Q4 2016 in Review

TDAM USA sold out of Dr. Reddy's Laboratories (RDY) in Q4 2016, closing a stake of 50,355 shares — an estimated $467K sold.

TDAM USA first reported a position in RDY in Q3 2014 and held it in 9 quarters. The position peaked at $1.3M in Q1 2015. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

  • TDAM USA reported no remaining Dr. Reddy's Laboratories position as of Q4 2016 after selling out during the quarter.
  • TDAM USA sold 50,355 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $467K.
  • TDAM USA first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 9 quarters.
  • TDAM USA's Dr. Reddy's Laboratories position peaked at $1.3M in Q1 2015.
  • 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on TDAM USA's 13F filing for Q4 2016, filed 8 Feb 2017.